• Media type: E-Article
  • Title: Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients
  • Contributor: Ergün, Mehmet; Brüggemann, Roger J. M.; Alanio, Alexandre; Dellière, Sarah; van Arkel, Andreas; Bentvelsen, Robbert G.; Rijpstra, Tom; van der Sar-van der Brugge, Simone; Lagrou, Katrien; Janssen, Nico A. F.; Buil, Jochem B.; van Dijk, Karin; Melchers, Willem J. G.; Reijers, Monique H. E.; Schouten, Jeroen A.; Wauters, Joost; Cordey, Alan; Soni, Shuchita; White, P. Lewis; van de Veerdonk, Frank L.; Verweij, Paul E.
  • Published: American Society for Microbiology, 2021
  • Published in: Journal of Clinical Microbiology, 59 (2021) 12
  • Language: English
  • DOI: 10.1128/jcm.01229-21
  • ISSN: 0095-1137; 1098-660X
  • Origination:
  • Footnote:
  • Description: <jats:p> The literature regarding COVID-19-associated pulmonary aspergillosis (CAPA) has shown conflicting observations, including survival of CAPA patients not receiving antifungal therapy and discrepancy between CAPA diagnosis and autopsy findings. To gain insight into the pathophysiology of CAPA, we performed a case-control study in which we compared <jats:named-content content-type="genus-species">Aspergillus</jats:named-content> test profiles in CAPA patients and controls in relation to intensive care unit (ICU) mortality. </jats:p>
  • Access State: Open Access